Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge

被引:8
|
作者
Miller, Edward J. [1 ,3 ]
Calamaras, Timothy [1 ]
Elezaby, Aly [1 ]
Sverdlov, Aaron [1 ]
Qin, Fuzhong [1 ,3 ]
Luptak, Ivan [1 ]
Wang, Ke [1 ]
Sun, Xinxin [1 ]
Vijay, Andrea [1 ]
Croteau, Dominique [1 ]
Bachschmid, Markus [2 ,3 ]
Cohen, Richard A. [2 ,3 ]
Walsh, Kenneth [3 ]
Colucci, Wilson S. [1 ,3 ]
机构
[1] Boston Med Ctr, Myocardial Biol Unit, Boston, MA USA
[2] Boston Med Ctr, Vasc Biol Unit, Boston, MA USA
[3] Boston Med Ctr, Whitaker Cardiovasc Inst, Boston, MA USA
来源
基金
英国医学研究理事会;
关键词
diabetes mellitus; heart failure; metabolism; obesity; POSTTRANSLATIONAL MODIFICATION; HEART-FAILURE; PREVENTS; RESVERATROL; ACTIVATION; SNRK;
D O I
10.1161/JAHA.115.002277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is a key activator of AMP-activated protein kinase and possibly other signaling pathways that oppose myocardial hypertrophy and failure. We hypothesized that LKB1 is essential to the heart's ability to withstand the metabolic stress of dietary excess. Methods and Results-Mice heterozygous for cardiac LKB1 were fed a control diet or a high-fat, high-sucrose diet for 4 months. On the control diet, cardiac LKB1 hearts had normal structure and function. After 4 months of the high-fat, high-sucrose diet, there was left ventricular hypertrophy and diastolic dysfunction in wild-type mice. In cardiac LKB1 (versus wild-type) mice, high-fat, high-sucrose feeding caused more hypertrophy (619 versus 553 mu m(2), P< 0.05), the de novo appearance of systolic dysfunction (left ventricular ejection fraction; 41% versus 59%, P< 0.01) with left ventricular dilation (3.6 versus 3.2 mm, P< 0.05), and more severe diastolic dysfunction with progression to a restrictive filling pattern (E/A ratio; 5.5 versus 1.3, P= 0.05). Myocardial dysfunction in hearts of cardiac LKB1 mice fed the high-fat, high-sucrose diet was associated with evidence of increased apoptosis and apoptotic signaling via caspase 3 and p53/PUMA (p53 upregulated modulator of apoptosis) and more severe mitochondrial dysfunction. Conclusions-Partial deficiency of cardiac LKB1 promotes the adverse effects of a high-fat, high-sucrose diet on the myocardium, leading to worsening of diastolic function and the de novo appearance of systolic dysfunction. LKB1 plays a key role in protecting the heart from the consequences of metabolic stress.
引用
收藏
页数:18
相关论文
共 23 条
  • [1] Cardiac LKB1 Deficiency Promotes Cardiac Dysfunction During Dietary Metabolic Challenge Independent of AMPK
    Miller, Edward J.
    Qin, Fuzhong
    Calamaras, Timothy
    Walsh, Kenneth
    Colucci, Wilson S.
    CIRCULATION, 2013, 128 (22)
  • [2] Autophagy and MEK inhibition promotes ferroptosis in liver kinase B1 (Lkb1)-deficient Kras-driven lung tumors
    Bhatt, Vrushank
    Lan, Taijin
    Wang, Wenping
    Kong, Jerry
    Lopes, Eduardo Cararo
    Khayati, Khoosheh
    Wang, Jianming
    Raju, Akash
    Rangel, Michael
    Lopez, Enrique
    Hu, Zhixian Sherrie
    Luo, Xuefei
    Su, Xiaoyang
    Malhotra, Jyoti
    Hu, Wenwei
    Pine, Sharon R.
    White, Eileen
    Guo, Jessie Yanxiang
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Chronic Lung Allograft Dysfunction: Role for Tumor Suppressor Gene Liver Kinase B1
    Rahman, M.
    Ravichandran, R.
    Bansal, S.
    Liu, W.
    Perincheri, S.
    Angara, S.
    Fleming, T.
    Bharat, A.
    Hachem, R.
    Smith, M.
    Bremner, R. M.
    Mohanakumar, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S60 - S60
  • [4] Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity
    Yuan, Tao
    Zeng, Chenming
    Liu, Jiawei
    Zhao, Chenxi
    Ge, Fujing
    Li, Yuekang
    Qian, Meijia
    Du, Jiamin
    Wang, Weihua
    Li, Yonghao
    Liu, Yue
    Dai, Xiaoyang
    Zhou, Jianya
    Chen, Xueqin
    Ma, Shenglin
    Zhu, Hong
    He, Qiaojun
    Yang, Bo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [5] Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity
    Tao Yuan
    Chenming Zeng
    Jiawei Liu
    Chenxi Zhao
    Fujing Ge
    Yuekang Li
    Meijia Qian
    Jiamin Du
    Weihua Wang
    Yonghao Li
    Yue Liu
    Xiaoyang Dai
    Jianya Zhou
    Xueqin Chen
    Shenglin Ma
    Hong Zhu
    Qiaojun He
    Bo Yang
    Signal Transduction and Targeted Therapy, 9
  • [6] The natural product antroalbol H promotes phosphorylation of liver kinase B1 (LKB1) at threonine 189 and thereby enhances cellular glucose uptake
    Wang, Fang
    Yang, Xiaoyan
    Lu, Yanting
    Li, Zhenghui
    Xu, Yuhui
    Hu, Jing
    Liu, Jikai
    Xiong, Wenyong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (27) : 10415 - 10427
  • [7] Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects
    Swisa, Avital
    Granot, Zvi
    Tamarina, Natalia
    Sayers, Sophie
    Bardeesy, Nabeel
    Philipson, Louis
    Hodson, David J.
    Wikstrom, Jakob D.
    Rutter, Guy A.
    Leibowitz, Gil
    Glaser, Benjamin
    Dor, Yuval
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (34) : 20934 - 20946
  • [8] Impact of Primary Graft Dysfunction on Exosomal Liver Kinase B1 Expression Following Lung Transplantation
    Rahman, M. A.
    Scozzi, D.
    Ravichandran, R.
    Bansal, S.
    Smith, M.
    Bremner, R.
    Mohanakumar, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S354 - S355
  • [9] TUMOR SUPPRESSOR GENE LIVER KINASE B1: NOVEL ROLE FOR THE PATHOGENESIS OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Rahman, Mohammad
    Ravichandran, Ranjithkumar
    Angara, Sureshbabu
    Fleming, Timothy
    Smith, Michael
    Bremner, Ross
    Mohanakumar, Thalachallour
    HUMAN IMMUNOLOGY, 2020, 81 : 22 - 22
  • [10] Endothelial Cell-Specific Liver Kinase B1 Deletion Causes Endothelial Dysfunction and Hypertension in Mice In Vivo
    Zhang, Wencheng
    Wang, Qilong
    Wu, Yue
    Moriasi, Cate
    Liu, Zhaoyu
    Dai, Xiaoyan
    Wang, Qiongxin
    Liu, Weimin
    Yuan, Zu-Yi
    Zou, Ming-Hui
    CIRCULATION, 2014, 129 (13) : 1428 - 1439